GLP-1 Agonists Retatrutide: Phase 2 and Phase 3 Clinical Trial Results Detailed analysis of retatrutide clinical data: from the Phase 2 NEJM study to Eli Lilly's Phase 3 TRIUMPH program. February 24, 2026 7 min read
